Jason Gardner

Biography

  Mr. Jason Gardner, Ph.D., is Cofounder of Magenta Therapeutics, Inc. and serves as Chief Executive Officer and President. Mr. Gardner joined Atlas Venture in November 2015 as an Atlas Advisor to create Magenta and has 21 years combined experience in stem cell science and industry leadership roles. He worked at GSK for 11 years, most recently as Vice President and Head of the R&D Satellite in Boston. He created and led the Regenerative Medicine Unit, established partnerships with The Harvard Stem Cell Institute and The Telethon Institute for Gene Therapy from which the first stem cell medicine (Strimvelis™) was approved. He was formerly a scientist at Progenics Pharmaceuticals and Chiron. Mr. Gardner was the Head of the Center of Excellence for External Drug Discovery (CEEDD) and was as a member of the clinical project team that led the late stage development and NDA approval for Tykerb™ for breast cancer. He serves as Director at Magenta Therapeutics, Inc. He has worked on multiple successful modalities across a range of therapeutic areas from target to launch. Mr. Gardner completed a postdoctoral fellowship in hematopoietic stem cells at Harvard Medical School. He was educated in the UK and holds a D.Phil. from Oxford University and M.A. and B.A. degrees from Cambridge University.

Research Interest

Stem Cell